Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Cervical Intraepithelial Neoplasia (CIN) Grade III With Non-invasive Physical Plasma

NCT04753073 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT04753073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04753073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Cervical Intraepithelial Neoplasia (CIN) Grade III With Non-invasive Physical Plasma
Lead sponsor
University Hospital Tuebingen
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2021
Completion date
June 30, 2024
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical intraepithelial neoplasia iii